Revisiting risk and benefit in early oncology trials in the era of precision medicine: A systematic review and meta-analysis of phase i trials of targeted single-agent anticancer therapies

Michael P. Mackley, Nicholas R. Fernandez, Benjamin Fletcher, Christy G. Woolcott, Conrad V. Fernandez

科研成果: 期刊稿件文献综述同行评审

18 引用 (Scopus)

指纹

探究 'Revisiting risk and benefit in early oncology trials in the era of precision medicine: A systematic review and meta-analysis of phase i trials of targeted single-agent anticancer therapies' 的科研主题。它们共同构成独一无二的指纹。

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry